sto 609 Search Results


90
Sino Biological sto 609
Sto 609, supplied by Sino Biological, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sto+609/10__1096_slash_fj__202002039rr-18-0-14?v=Sino+Biological
Average 90 stars, based on 1 article reviews
sto 609 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

93
Tocris sto 609 acetate
Sto 609 Acetate, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sto+609/pmc05592668-321-0-6?v=Tocris
Average 93 stars, based on 1 article reviews
sto 609 acetate - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier

94
Tocris sto 609
Sto 609, supplied by Tocris, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sto+609/pmc05603587-33-1-12?v=Tocris
Average 94 stars, based on 1 article reviews
sto 609 - by Bioz Stars, 2026-06
94/100 stars
  Buy from Supplier

94
Selleck Chemicals sto 609
Sto 609, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sto+609/pmc10904047__jci___134___172262___s221-388-77-81?v=Selleck+Chemicals
Average 94 stars, based on 1 article reviews
sto 609 - by Bioz Stars, 2026-06
94/100 stars
  Buy from Supplier

92
Santa Cruz Biotechnology sto 609
Sto 609, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sto+609/pmc05121333-271-0-5?v=Santa+Cruz+Biotechnology
Average 92 stars, based on 1 article reviews
sto 609 - by Bioz Stars, 2026-06
92/100 stars
  Buy from Supplier

90
Cayman Chemical camkk inhibitor #15325
Camkk Inhibitor #15325, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sto+609/pmc05122337-98-5-38?v=Cayman+Chemical
Average 90 stars, based on 1 article reviews
camkk inhibitor #15325 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
FUJIFILM sto-609
Inhibitors of CaMKs and CaMKK suppress ionomycin-induced cofilin phosphorylation and neurite outgrowth. A, effects of inhibitors on ionomycin-induced cofilin phosphorylation. Neuro-2a cells were pretreated with control DMSO, 3 μm KN-93, or 5 μm <t>STO-609</t> for 1 h and then stimulated with 1.5 μm ionomycin for 30 min. Cell lysates were analyzed by immunoblotting (IB) with anti-P-cofilin and anti-cofilin antibodies. The relative P-cofilin levels are shown as means ± S.D. of triplicate experiments. **, p < 0.001. B, effects of inhibitors on ionomycin-induced neurite outgrowth. Neuro-2a cells transfected with CFP were pretreated with control DMSO, KN-93, or STO-609 and stimulated with ionomycin as in A. Cells were cultured for 48 h and fixed, and their CFP fluorescence was visualized. The arrows indicate neurite-bearing cells. Scale bar, 10 μm. C, quantitative analysis of the data shown in B. The number of neurite-bearing cells was analyzed as in Fig. 3A. Data represent means ± S.D. of triplicate experiments (60–80 cells in each experiment). *, p < 0.01.
Sto 609, supplied by FUJIFILM, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sto+609/pmc02781398-122-2-6?v=FUJIFILM
Average 90 stars, based on 1 article reviews
sto-609 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Topscience Co Ltd sto–609
Inhibitors of CaMKs and CaMKK suppress ionomycin-induced cofilin phosphorylation and neurite outgrowth. A, effects of inhibitors on ionomycin-induced cofilin phosphorylation. Neuro-2a cells were pretreated with control DMSO, 3 μm KN-93, or 5 μm <t>STO-609</t> for 1 h and then stimulated with 1.5 μm ionomycin for 30 min. Cell lysates were analyzed by immunoblotting (IB) with anti-P-cofilin and anti-cofilin antibodies. The relative P-cofilin levels are shown as means ± S.D. of triplicate experiments. **, p < 0.001. B, effects of inhibitors on ionomycin-induced neurite outgrowth. Neuro-2a cells transfected with CFP were pretreated with control DMSO, KN-93, or STO-609 and stimulated with ionomycin as in A. Cells were cultured for 48 h and fixed, and their CFP fluorescence was visualized. The arrows indicate neurite-bearing cells. Scale bar, 10 μm. C, quantitative analysis of the data shown in B. The number of neurite-bearing cells was analyzed as in Fig. 3A. Data represent means ± S.D. of triplicate experiments (60–80 cells in each experiment). *, p < 0.01.
Sto–609, supplied by Topscience Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sto+609/pmc11929195-54-5-16?v=Topscience+Co+Ltd
Average 90 stars, based on 1 article reviews
sto–609 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
MedKoo Inc sto-609
Inhibitors of CaMKs and CaMKK suppress ionomycin-induced cofilin phosphorylation and neurite outgrowth. A, effects of inhibitors on ionomycin-induced cofilin phosphorylation. Neuro-2a cells were pretreated with control DMSO, 3 μm KN-93, or 5 μm <t>STO-609</t> for 1 h and then stimulated with 1.5 μm ionomycin for 30 min. Cell lysates were analyzed by immunoblotting (IB) with anti-P-cofilin and anti-cofilin antibodies. The relative P-cofilin levels are shown as means ± S.D. of triplicate experiments. **, p < 0.001. B, effects of inhibitors on ionomycin-induced neurite outgrowth. Neuro-2a cells transfected with CFP were pretreated with control DMSO, KN-93, or STO-609 and stimulated with ionomycin as in A. Cells were cultured for 48 h and fixed, and their CFP fluorescence was visualized. The arrows indicate neurite-bearing cells. Scale bar, 10 μm. C, quantitative analysis of the data shown in B. The number of neurite-bearing cells was analyzed as in Fig. 3A. Data represent means ± S.D. of triplicate experiments (60–80 cells in each experiment). *, p < 0.01.
Sto 609, supplied by MedKoo Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sto+609/pmc10472110-106-16-17?v=MedKoo+Inc
Average 90 stars, based on 1 article reviews
sto-609 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
CSNpharm Inc sto-609 #csn19242
Inhibitors of CaMKs and CaMKK suppress ionomycin-induced cofilin phosphorylation and neurite outgrowth. A, effects of inhibitors on ionomycin-induced cofilin phosphorylation. Neuro-2a cells were pretreated with control DMSO, 3 μm KN-93, or 5 μm <t>STO-609</t> for 1 h and then stimulated with 1.5 μm ionomycin for 30 min. Cell lysates were analyzed by immunoblotting (IB) with anti-P-cofilin and anti-cofilin antibodies. The relative P-cofilin levels are shown as means ± S.D. of triplicate experiments. **, p < 0.001. B, effects of inhibitors on ionomycin-induced neurite outgrowth. Neuro-2a cells transfected with CFP were pretreated with control DMSO, KN-93, or STO-609 and stimulated with ionomycin as in A. Cells were cultured for 48 h and fixed, and their CFP fluorescence was visualized. The arrows indicate neurite-bearing cells. Scale bar, 10 μm. C, quantitative analysis of the data shown in B. The number of neurite-bearing cells was analyzed as in Fig. 3A. Data represent means ± S.D. of triplicate experiments (60–80 cells in each experiment). *, p < 0.01.
Sto 609 #Csn19242, supplied by CSNpharm Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sto+609/pmc11808498-11-19-24?v=CSNpharm+Inc
Average 90 stars, based on 1 article reviews
sto-609 #csn19242 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
ApexBio sto-609
Inhibitors of CaMKs and CaMKK suppress ionomycin-induced cofilin phosphorylation and neurite outgrowth. A, effects of inhibitors on ionomycin-induced cofilin phosphorylation. Neuro-2a cells were pretreated with control DMSO, 3 μm KN-93, or 5 μm <t>STO-609</t> for 1 h and then stimulated with 1.5 μm ionomycin for 30 min. Cell lysates were analyzed by immunoblotting (IB) with anti-P-cofilin and anti-cofilin antibodies. The relative P-cofilin levels are shown as means ± S.D. of triplicate experiments. **, p < 0.001. B, effects of inhibitors on ionomycin-induced neurite outgrowth. Neuro-2a cells transfected with CFP were pretreated with control DMSO, KN-93, or STO-609 and stimulated with ionomycin as in A. Cells were cultured for 48 h and fixed, and their CFP fluorescence was visualized. The arrows indicate neurite-bearing cells. Scale bar, 10 μm. C, quantitative analysis of the data shown in B. The number of neurite-bearing cells was analyzed as in Fig. 3A. Data represent means ± S.D. of triplicate experiments (60–80 cells in each experiment). *, p < 0.01.
Sto 609, supplied by ApexBio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sto+609/pmc07595405-118-0-17?v=ApexBio
Average 90 stars, based on 1 article reviews
sto-609 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Enzo Biochem sto-609
(A) Steady-state levels of plasma <t>STO-609.</t> (B) Tissue levels after 4 weeks treatment with 30 mg/ml STO-609. Data for (A) and (B) are means ± SEM (n=3). (C) Wet weight of prostate normalised to body weight following 6 weeks of STO-609 treatment (n=7–8 mice for each condition). Data are means ± SEM; **P<0.01. (D) Representative images of anterior prostate lobe from vehicle and STO-609 treated mice. (E) Quantification of pathological grading from vehicle and STO-609 treated mice. The graph shows the highest grade lesion observed in each prostate section (n=5 mice per condition).
Sto 609, supplied by Enzo Biochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sto+609/pmc06295249-231-20-21?v=Enzo+Biochem
Average 90 stars, based on 1 article reviews
sto-609 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

Image Search Results


Inhibitors of CaMKs and CaMKK suppress ionomycin-induced cofilin phosphorylation and neurite outgrowth. A, effects of inhibitors on ionomycin-induced cofilin phosphorylation. Neuro-2a cells were pretreated with control DMSO, 3 μm KN-93, or 5 μm STO-609 for 1 h and then stimulated with 1.5 μm ionomycin for 30 min. Cell lysates were analyzed by immunoblotting (IB) with anti-P-cofilin and anti-cofilin antibodies. The relative P-cofilin levels are shown as means ± S.D. of triplicate experiments. **, p < 0.001. B, effects of inhibitors on ionomycin-induced neurite outgrowth. Neuro-2a cells transfected with CFP were pretreated with control DMSO, KN-93, or STO-609 and stimulated with ionomycin as in A. Cells were cultured for 48 h and fixed, and their CFP fluorescence was visualized. The arrows indicate neurite-bearing cells. Scale bar, 10 μm. C, quantitative analysis of the data shown in B. The number of neurite-bearing cells was analyzed as in Fig. 3A. Data represent means ± S.D. of triplicate experiments (60–80 cells in each experiment). *, p < 0.01.

Journal: The Journal of Biological Chemistry

Article Title: Ca 2+ /Calmodulin-dependent Protein Kinase IV-mediated LIM Kinase Activation Is Critical for Calcium Signal-induced Neurite Outgrowth *

doi: 10.1074/jbc.M109.006296

Figure Lengend Snippet: Inhibitors of CaMKs and CaMKK suppress ionomycin-induced cofilin phosphorylation and neurite outgrowth. A, effects of inhibitors on ionomycin-induced cofilin phosphorylation. Neuro-2a cells were pretreated with control DMSO, 3 μm KN-93, or 5 μm STO-609 for 1 h and then stimulated with 1.5 μm ionomycin for 30 min. Cell lysates were analyzed by immunoblotting (IB) with anti-P-cofilin and anti-cofilin antibodies. The relative P-cofilin levels are shown as means ± S.D. of triplicate experiments. **, p < 0.001. B, effects of inhibitors on ionomycin-induced neurite outgrowth. Neuro-2a cells transfected with CFP were pretreated with control DMSO, KN-93, or STO-609 and stimulated with ionomycin as in A. Cells were cultured for 48 h and fixed, and their CFP fluorescence was visualized. The arrows indicate neurite-bearing cells. Scale bar, 10 μm. C, quantitative analysis of the data shown in B. The number of neurite-bearing cells was analyzed as in Fig. 3A. Data represent means ± S.D. of triplicate experiments (60–80 cells in each experiment). *, p < 0.01.

Article Snippet: KN-93 and STO-609 were purchased from Wako (Osaka, Japan).

Techniques: Western Blot, Transfection, Cell Culture, Fluorescence

(A) Steady-state levels of plasma STO-609. (B) Tissue levels after 4 weeks treatment with 30 mg/ml STO-609. Data for (A) and (B) are means ± SEM (n=3). (C) Wet weight of prostate normalised to body weight following 6 weeks of STO-609 treatment (n=7–8 mice for each condition). Data are means ± SEM; **P<0.01. (D) Representative images of anterior prostate lobe from vehicle and STO-609 treated mice. (E) Quantification of pathological grading from vehicle and STO-609 treated mice. The graph shows the highest grade lesion observed in each prostate section (n=5 mice per condition).

Journal: Cancer research

Article Title: CAMKK2 promotes prostate cancer independently of AMPK via increased lipogenesis

doi: 10.1158/0008-5472.CAN-18-0585

Figure Lengend Snippet: (A) Steady-state levels of plasma STO-609. (B) Tissue levels after 4 weeks treatment with 30 mg/ml STO-609. Data for (A) and (B) are means ± SEM (n=3). (C) Wet weight of prostate normalised to body weight following 6 weeks of STO-609 treatment (n=7–8 mice for each condition). Data are means ± SEM; **P<0.01. (D) Representative images of anterior prostate lobe from vehicle and STO-609 treated mice. (E) Quantification of pathological grading from vehicle and STO-609 treated mice. The graph shows the highest grade lesion observed in each prostate section (n=5 mice per condition).

Article Snippet: Osmotic minipumps (Models 2004/2006, Alzet Osmotic Pumps, Cupertino, USA) were filled with varying concentrations (6, 15 and 30 mg/ml) of STO-609 (Enzo Life Sciences) in 200 mM NaOH.

Techniques: